Transcatheter Aortic Valve Implantation: Recent Advances and Future Prospects

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 28 June 2024 | Viewed by 933

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cardiology, Mitera General Hospital, 151 23 Athens, Greece
Interests: complex PCI; mchronic total occlusion percutaneous revascularization; intravascular imaging; transcatheter aortic valve implantation

E-Mail Website
Guest Editor
St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SE1 7EH, UK
Interests: structural heart interventions; transcatheter aortic valve implantation; transcatheter edge-to-edge repair of mitral valve; percutaneous coronary artery interventions

Special Issue Information

Dear Colleagues,

Transcatheter aortic valve implantation (TAVI) has utterly reformed the management of symptomatic severe aortic stenosis. As new technologies have been introduced and techniques of implantation have been revolutionized, TAVI has now become the leading therapeutic strategy for aortic valve replacement in most patients with severe symptomatic AS. The more contemporary minimalistic approach using conscious sedation or even just local anesthesia, the adaptation of techniques to improve commissural alignment and facilitate coronary access after implantation, the innovation regarding the TAVI bioprosthesis with technologies to further improve valve durability along with accumulating experience have resulted in a substantial reduction in procedural complications and improvement of post-TAVI short- and long-term outcomes.

We are pleased to invite you to submit articles regarding the forthcoming Special Issue entitled “Transcatheter Aortic Valve Implantation: Recent Advances and Future Prospects”.

In this Special Issue, we are aiming to provide a review on the current status and the fundamental aspects regarding the TAVI procedure. The topic editors encourage the submission of articles highlighting the latest advances in the field, and present interesting data with regards to the role of revascularization and commissural alignment in patients undergoing TAVI and direct comparison of different TAVI bioprostheses (balloon-expandable vs. self-expandable) in several areas including need for pacemaker post-TAVI , haemodynamic performance and paravalvular leaks. In addition, this Special issue will aim to include opinions regarding several future perspectives such as the lifetime management of younger patients with severe AS, the role of TAVI in patients with bicuspid aortic valves and aortic stenosis, pure aortic regurgitation, and those with asymptomatic aortic stenosis.

In this Special Issue, original articles and reviews are welcome. Research areas may include but are not limited to the following:

  1. Outcomes post-TAVI;
  2. Comparison of different bioprostheses regarding haemodynamic performance post-TAVI, rates of PPM implantation and paravalvular leaks;
  3. The role of revascularization in patients undergoing TAVI;
  4. Lifelong management of patients with severe aortic stenosis;
  5. TAVI and minimalistic approach;
  6. Comparison of different access routes during TAVI.

Dr. Andreas S. Kalogeropoulos
Dr. Tiffany Patterson
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • TAVI
  • TAVR
  • aortic stenosis
  • bioprosthesis
  • paravalvular leak
  • CT TAVI
  • transfemoral
  • TAVI access
  • PPM post-TAVI
  • commissural alignment

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1557 KiB  
Article
Clinical Implication of Supra-Normal Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Replacement
by Teruhiko Imamura, Yuki Hida, Hiroshi Ueno, Koichiro Kinugawa, Fumiaki Yashima, Norio Tada, Masahiro Yamawaki, Shinichi Shirai, Toru Naganuma, Futoshi Yamanaka, Masahiko Noguchi, Kazuki Mizutani, Kensuke Takagi, Yusuke Watanabe, Masanori Yamamoto, Masahiko Asami, Masaki Izumo, Yohei Ohno, Hidetaka Nishida, Kentaro Hayashida and on behalf of the OCEAN-TAVI Investigatorsadd Show full author list remove Hide full author list
J. Clin. Med. 2023, 12(23), 7429; https://doi.org/10.3390/jcm12237429 - 30 Nov 2023
Cited by 1 | Viewed by 759
Abstract
Background: Individuals with heart failure displaying supra-normal left ventricular ejection fraction (snLVEF) may exhibit less favorable clinical outcomes in contrast to their counterparts with normal left ventricular ejection fraction (nLVEF). The distinctive characteristics and mid-term prognosis of individuals with severe aortic stenosis and [...] Read more.
Background: Individuals with heart failure displaying supra-normal left ventricular ejection fraction (snLVEF) may exhibit less favorable clinical outcomes in contrast to their counterparts with normal left ventricular ejection fraction (nLVEF). The distinctive characteristics and mid-term prognosis of individuals with severe aortic stenosis and snLVEF following transcatheter aortic valve replacement (TAVR) remain enigmatic. Methods: Among 7393 patients diagnosed with severe aortic stenosis who underwent TAVR between 2013 and 2019 and were enlisted in the optimized transcatheter valvular intervention (OCEAN-TAVI) multicenter registry (UMIN000020423), we selected patients with left ventricular ejection fraction (LVEF) ≥ 50%. snLVEF was defined as LVEF exceeding 65%. We compared the baseline characteristics and assessed three-year post-TAVR mortality and heart failure readmission rates between the snLVEF (LVEF > 65%) and nLVEF cohorts (LVER 50–65%). Results: Our study cohort comprised 5989 patients (mean age 84.4 ± 5.1 years and 1783 males). Among these, 2819 patients were categorized within the snLVEF cohort, while the remaining 3170 were allocated to the nLVEF group. Individuals within the snLVEF cohort were more likely to be female and displayed lower levels of natriuretic peptides, as well as smaller left ventricular dimensions in comparison to their nLVEF counterparts (p < 0.05 for all). The presence of snLVEF emerged as an independent predictor of the three-year composite endpoint relative to nLVEF, with an adjusted hazard ratio of 1.16 (95% confidence interval 1.02–1.31, p = 0.023) after accounting for several potential confounding factors. Conclusions: snLVEF was relatively common among candidates for TAVR with preserved ejection fraction. Patients harboring snLVEF appear to manifest a distinctive clinical profile and encounter less favorable clinical outcomes following TAVR in contrast to those characterized by nLVEF. Full article
Show Figures

Figure 1

Back to TopTop